期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Transceiver Optimization for Multi-Antenna Device-to-Device Communications 被引量:1
1
作者 Daohua Zhu yajuan guo +4 位作者 Lei Wei Chaoyang Zhu Biyao Huang Wei Xu Chunming Zhao 《China Communications》 SCIE CSCD 2016年第5期110-121,共12页
It has been shown that the deployment of device-to-device(D2D) communication in cellular systems can provide better support for local services. However, improper design of the hybrid system may cause severe interferen... It has been shown that the deployment of device-to-device(D2D) communication in cellular systems can provide better support for local services. However, improper design of the hybrid system may cause severe interference between cellular and D2D links. In this paper, we consider transceiver design for the system employing multiple antennas to mitigate the interference. The precoder and decoder matrices are optimized in terms of sum mean squared error(MSE) and capacity, respectively. For the MSE minimization problem, we present an alternative transceiver optimization algorithm. While for the non-convex capacity maximization problem, we decompose the primal problem into a sequence of standard convex quadratic programs for efficient optimization. The evaluation of our proposed algorithms for performance enhancement of the entire D2D integrated cellular system is carried out through simulations. 展开更多
关键词 优化算法 天线设备 收发信机 设备通信 混合系统设计 蜂窝系统 最小化问题 最大化问题
下载PDF
含生长因子骨移植材料的研究进展和监管现状
2
作者 郭晓磊 李晓云 +3 位作者 孙嘉怿 金乐 郭亚娟 史新立 《中华老年骨科与康复电子杂志》 2023年第6期373-378,共6页
骨移植材料接受食品药品监督管理局(FDA)不同路径的监管审批,其预期的安全性和有效性可能只有FDA审评者清楚,临床医生有必要对监管过程有所了解。FDA的审批路径主要包括4个监管途径:510K批准、研究器械豁免/上市前批准(IDE/PMA)、人细... 骨移植材料接受食品药品监督管理局(FDA)不同路径的监管审批,其预期的安全性和有效性可能只有FDA审评者清楚,临床医生有必要对监管过程有所了解。FDA的审批路径主要包括4个监管途径:510K批准、研究器械豁免/上市前批准(IDE/PMA)、人细胞、组织和细胞基产品(HTC/P)和再生医学先进治疗(RMAT)。骨再生修复过程中涉及到多种生长因子,如骨形态发生蛋白-2、4(BMP-2,4)、成纤维细胞生长因子、血管内皮生长因子、血小板源性生长因子(PDGF)和胰岛素样生长因子-1等。Infuse(BMP-2)是重组骨形态蛋白-2(rhBMP-2)与可吸收胶原海绵结合的骨移植材料。骨形成蛋白-1(OP-1)材料2001年获得FDA批准用于替代自体骨移植治疗长骨顽固性骨不愈合。PDGF-BB材料是rhPDGF与β-磷酸三钙结合制成,2015年获得FDA批准用于踝关节融合术。iFactorTM是P-15吸附在无机矿物物质上在水凝胶载体中制成的肽增强骨移植材料,2005年FDA批准可用于单节段颈椎前路椎间融合术。我国已有4家公司含生长因子的骨移植材料获得国家药品监督管理局批准,所含的生长因子均为rhBMP-2,与国外相比产品的种类还有很大的差距。组织工程骨材料是组织工程三要素即支架、细胞、生长因子的有效结合,将使骨移植材料的科技含量、有效性得到进一步提高。国家药品监督管理局对骨移植材料应根据产品组成进行分类细化,增加审批路径,提高监管水平,促进科研成果的转化。 展开更多
关键词 骨再生 骨移植 骨替代材料 生长因子 骨形态发生蛋白
原文传递
Biodegradable metals for bone defect repair:A systematic review and meta-analysis based on animal studies 被引量:5
3
作者 Jiazhen Zhang Yanbiao Jiang +9 位作者 Zhizhong Shang Bing Zhao Mingyue Jiao Wenbo Liu Maobo Cheng Bao Zhai yajuan guo Bin Liu Xinli Shi Bin Ma 《Bioactive Materials》 SCIE 2021年第11期4027-4052,共26页
Biodegradable metals are promising candidates for bone defect repair.With an evidence-based approach,this study investigated and analyzed the performance and degradation properties of biodegradable metals in animal mo... Biodegradable metals are promising candidates for bone defect repair.With an evidence-based approach,this study investigated and analyzed the performance and degradation properties of biodegradable metals in animal models for bone defect repair to explore their potential clinical translation.Animal studies on bone defect repair with biodegradable metals in comparison with other traditional biomaterials were reviewed.Data was carefully collected after identification of population,intervention,comparison,outcome,and study design(PICOS),and following the inclusion criteria of biodegradable metals in animal studies.30 publications on pure Mg,Mg alloys,pure Zn and Zn alloys were finally included after extraction from a collected database of 2543 publications.A qualitative systematic review and a quantitative meta-analysis were performed.Given the heterogeneity in animal model,anatomical site and critical size defect(CSD),biodegradable metals exhibited mixed effects on bone defect repair and degradation in animal studies in comparison with traditional non-degradable metals,biodegradable polymers,bioceramics,and autogenous bone grafts.The results indicated that there were limitations in the experimental design of the included studies,and quality of the evidence presented by the studies was very low.To enhance clinical translation of biodegradable metals,evidence-based research with data validity is needed.Future studies should adopt standardized experimental protocols in investigating the effects of biodegradable metals on bone defect repair with animal models. 展开更多
关键词 Biodegradable metals Bone defect repair Animal model Systematic review and meta-analysis Regulatory science Safety and effectiveness
原文传递
miR-7/TGF-β2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis 被引量:2
4
作者 Tao Su Suchao Huang +15 位作者 Yanmin Zhang yajuan guo Shuwei Zhang Jiaji Guan Mingjing Meng Linxin Liu Caiyan Wang Dihua Yu Hiu-Yee Kwan Zhiying Huang Qiuju Huang Elaine Lai-Han Leung Ming Hu Ying Wang Zhongqiu Liu Linlin Lu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第2期821-837,共17页
Acidosis,regardless of hypoxia involvement,is recognized as a chronic and harsh tumor microenvironment(TME)that educates malignant cells to thrive and metastasize.Although overwhelming evidence supports an acidic envi... Acidosis,regardless of hypoxia involvement,is recognized as a chronic and harsh tumor microenvironment(TME)that educates malignant cells to thrive and metastasize.Although overwhelming evidence supports an acidic environment as a driver or ubiquitous hallmark of cancer progression,the unrevealed core mechanisms underlying the direct effect of acidification on tumorigenesis have hindered the discovery of novel therapeutic targets and clinical therapy.Here,chemical-induced and transgenic mouse models for colon,liver and lung cancer were established,respectively.miR-7 and TGF-β2 expressions were examined in clinical tissues(n=184).RNA-seq,miRNA-seq,proteomics,biosynthesis analyses and functional studies were performed to validate the mechanisms involved in the acidic TME-induced lung cancer metastasis.Our data show that lung cancer is sensitive to the increased acidification of TME,and acidic TME-induced lung cancer metastasis via inhibition of miR-7-5 p.TGF-β2 is a direct target of miR-7-5 p.The reduced expression of miR-7-5 p subsequently increases the expression of TGF-β2 which enhances the metastatic potential of the lung cancer.Indeed,overexpression of miR-7-5 p reduces the acidic p H-enhanced lung cancer metastasis.Furthermore,the human lung tumor samples also show a reduced miR-7-5 p expression but an elevated level of activated TGF-β2;the expressions of both miR-7-5 p and TGF-β2 are correlated with patients’survival.We are the first to identify the role of the miR-7/TGF-β2 axis in acidic p H-enhanced lung cancer metastasis.Our study not only delineates how acidification directly affects tumorigenesis,but also suggests miR-7 is a novel reliable biomarker for acidic TME and a novel therapeutic target for non-small cell lung cancer(NSCLC)treatment.Our study opens an avenue to explore the p H-sensitive subcellular components as novel therapeutic targets for cancer treatment. 展开更多
关键词 Acidic tumor microenvironment miR-7-5p TGF-Β2 METASTASIS Lung cancer pH INVASION
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部